Skip to content

Evaluation of stent angioplasty as a therapeutic option in the treatment of arteriosclerotic lesions of the common femoral artery.

Evaluation of stent angioplasty as a therapeutic option in the treatment of arteriosclerotic lesions of the common femoral artery.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00024584
Enrollment
300
Registered
2021-02-19
Start date
2021-02-16
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I70.20

Interventions

Group 1: Retrospective Analysis after stent angioplasty of the common femoral artery

Sponsors

Universitäts-Herzzentrum Bad Krozingen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Clinical stage IIa-IV according to Fontaine/ 2-5 Rutherford-Becker. Angiography: Arteriosclerotic stenosis (> 70% diameter reduction) or occlusion of the femoral artery.

Exclusion criteria

Exclusion criteria: No stent angioplasty in the common femoral artery

Design outcomes

Primary

MeasureTime frame
Rate of target lesion revascularization (TLR) at the target lesion.

Secondary

MeasureTime frame
Time to first reintervention at target lesion (TLR). Rate of TLR at 12 and 24 months. Primary and secondary patency rates of the target lesion 12 and 24 months after the index procedure. Rate of minor and major amputations on the treated leg 12 and 24 months after the index procedure. Leg preservation rate at 12 and 24 months. Clinical improvement using the Rutherford-Becker classification (see Appendix). Serious cardiovascular events (myocardial infarction, stroke, major amputation, death) 12 and 24 months after the index procedure. Number of ipsilateral punctures of the common femoral artery.

Countries

Germany

Contacts

Public ContactTanja Böhme

Universitäts-Herzzentrum Bad Krozingen

Tanja.Boehme@universitaets-herzzentrum.de004976334020

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026